BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2674968)

  • 1. Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
    Bree F; Houin G; Barre J; Riant P; Tillement JP
    Prog Clin Biol Res; 1989; 300():321-36. PubMed ID: 2674968
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
    Meijer DK; van der Sluijs P
    Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug binding sites on human alpha-1-acid glycoprotein.
    Müller WE
    Prog Clin Biol Res; 1989; 300():363-78. PubMed ID: 2674971
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood binding and tissue transfer of drugs: the influence of alpha 1 acid glycoprotein binding.
    Belaiba R; Riant P; Urien S; Brée F; Albengres E; Barré J; Tillement JP
    Prog Clin Biol Res; 1989; 300():287-305. PubMed ID: 2674966
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of age-related alteration of plasma alpha 1-acid glycoprotein concentration on erythromycin pharmacokinetics in pigs.
    Kinoshita T; Son DS; Shimoda M; Kokue E
    Am J Vet Res; 1995 Mar; 56(3):362-5. PubMed ID: 7771705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein.
    Belpaire FM; Bogaert MG
    Prog Clin Biol Res; 1989; 300():337-50. PubMed ID: 2674969
    [No Abstract]   [Full Text] [Related]  

  • 8. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
    Alván G
    Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
    [No Abstract]   [Full Text] [Related]  

  • 12. Indapamide binding to alpha 1-acid glycoprotein: consequences on its blood distribution and plasma binding in disease states.
    Urien S; Guez D; Thénot A; Tillement JP
    Prog Clin Biol Res; 1989; 300():449-52. PubMed ID: 2780643
    [No Abstract]   [Full Text] [Related]  

  • 13. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):40-3. PubMed ID: 14749548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between binding of benzodiazepines to alpha-1-acid glycoprotein and human serum albumin and their retention on the protein and octadecylsilane columns.
    Sadlej-Sosnowska N
    Biomed Chromatogr; 1995; 9(3):150-1. PubMed ID: 7655304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug binding to plasma proteins.
    Paxton JW
    N Z Med J; 1985 Apr; 98(776):245-8. PubMed ID: 3857503
    [No Abstract]   [Full Text] [Related]  

  • 18. Elementary pharmacokinetics in clinical practice. 6: Drug concentration monitoring.
    Paxton JW
    N Z Med J; 1982 Mar; 95(703):150-3. PubMed ID: 6952127
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein binding predictions in infants.
    McNamara PJ; Alcorn J
    AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction of drugs with alpha 1-acid glycoprotein (orosomucoid)].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1987; 50(5):110-9. PubMed ID: 3319686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.